These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 14602191

  • 1. Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam.
    Mahaguna V, Talbert RL, Peters JI, Adams S, Reynolds TD, Lam FY, Williams RO.
    Eur J Pharm Biopharm; 2003 Nov; 56(3):461-8. PubMed ID: 14602191
    [Abstract] [Full Text] [Related]

  • 2. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
    Williams RO, Sykora MA, Mahaguna V.
    AAPS PharmSciTech; 2001 Jun 09; 2(2):E8. PubMed ID: 14727883
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH, Huang Y, Moore AD.
    Drug Dev Ind Pharm; 2002 May 09; 28(5):601-8. PubMed ID: 12098849
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Study the effect of formulation variables on drug release from hydrophilic matrix tablets of milnacipran and prediction of in-vivo plasma profile.
    Singhvi G, Shah A, Yadav N, Saha RN.
    Pharm Dev Technol; 2014 Sep 09; 19(6):708-16. PubMed ID: 23931031
    [Abstract] [Full Text] [Related]

  • 8. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation.
    Roshdy MN, Schnaare RL, Sugita ET, Schwartz JB.
    Pharm Dev Technol; 2002 May 09; 7(2):155-68. PubMed ID: 12066571
    [Abstract] [Full Text] [Related]

  • 9. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin.
    Lee BJ, Ryu SG, Cui JH.
    Drug Dev Ind Pharm; 1999 Apr 09; 25(4):493-501. PubMed ID: 10194604
    [Abstract] [Full Text] [Related]

  • 10. Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.
    Klančar U, Baumgartner S, Legen I, Smrdel P, Kampuš NJ, Krajcar D, Markun B, Kočevar K.
    AAPS PharmSciTech; 2015 Apr 09; 16(2):398-406. PubMed ID: 25331194
    [Abstract] [Full Text] [Related]

  • 11. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z, Fassihi R.
    AAPS PharmSciTech; 2017 Feb 09; 18(2):462-472. PubMed ID: 27106916
    [Abstract] [Full Text] [Related]

  • 12. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ, Ryu SG, Cui JH.
    Int J Pharm; 1999 Oct 15; 188(1):71-80. PubMed ID: 10528084
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R, Kim YI, Chang SW, Kim JO.
    Int J Pharm; 2014 Jan 02; 460(1-2):205-11. PubMed ID: 24184032
    [Abstract] [Full Text] [Related]

  • 17. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S, Bodmeier R.
    Int J Pharm; 2010 Dec 15; 402(1-2):72-7. PubMed ID: 20883759
    [Abstract] [Full Text] [Related]

  • 18. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
    Cao QR, Choi JS, Liu Y, Xu WJ, Yang M, Lee BJ, Cui JH.
    Drug Dev Ind Pharm; 2013 Nov 15; 39(11):1720-30. PubMed ID: 23062115
    [Abstract] [Full Text] [Related]

  • 19. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
    Castellanos Gil E, Iraizoz Colarte A, Lara Sampedro JL, Bataille B.
    Eur J Pharm Biopharm; 2008 May 15; 69(1):303-11. PubMed ID: 18053697
    [Abstract] [Full Text] [Related]

  • 20. Diffusion in HPMC gels. II. Prediction of drug release rates from hydrophilic matrix extended-release dosage forms.
    Gao P, Nixon PR, Skoug JW.
    Pharm Res; 1995 Jul 15; 12(7):965-71. PubMed ID: 7494816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.